AnaptysBio, Inc. (ANAB)
58.88
+7.61
(+14.84%)
USD |
NASDAQ |
Apr 24, 16:00
59.02
+0.14
(+0.24%)
After-Hours: 20:00
AnaptysBio Market Cap : 1.693B for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vanda Pharmaceuticals, Inc. | 407.25M |
| ADMA Biologics, Inc. | 2.682B |
| Nektar Therapeutics | 1.586B |
| Rigel Pharmaceuticals, Inc. | 559.55M |
| Axsome Therapeutics, Inc. | 9.512B |
Market Cap Related Metrics
| PS Ratio | 7.518 |
| Price to Book Value | 45.49 |
| Price to Free Cash Flow | 89.94 |
| Price | 58.88 |
| Earnings Yield | -0.88% |
| Operating PE Ratio | 36.82 |